$0.8389
0.04365.48%
마지막 업데이트: Oct 23, 8:45 AM
Benzinga
Benzinga
Benzinga
금요일, 10월 23
Benzinga
© 2026 Benzinga | All Rights Reserved
Inovio Pharmaceuticals (INO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.25 | $-0.32 | $-0.35 | $-0.49 |
| Actual | $-0.07 | $-0.28 | $-0.26 | $-0.44 |
| Surprise | +72.0% | +12.5% | +25.7% | +10.2% |
| Revenue | ||||
| Estimate | $400000 | $250000 | $20000 | $8330 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.20 | $-0.18 | $-0.18 | $-0.13 |
| Revenue | ||||
| Consensus | $3.6M | $833336 | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.07 | $-0.25 | 72.0 % |
| Q1 | May 13, 2026 | $-0.28 | $-0.32 | 12.5 % |
| Q4 | Mar 12, 2026 | $-0.26 | $-0.35 | 25.7 % |
| Q3 | Nov 10, 2025 | $-0.44 | $-0.49 | 10.2 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $0 | $400.00K | -100.0 % |
| Q1 | May 13, 2026 | $0 | $250.00K | -100.0 % |
| Q4 | Mar 12, 2026 | $0 | $20.00K | -100.0 % |
| Q3 | Nov 10, 2025 | $0 | $8.33K | -100.0 % |